Powering

Early Cancer Diagnostics

We invest in blood-based early cancer screening technologies.
We are an appointed accelerator under Enterprise Singapore’s sector-specific accelerator program for MedTech.

Revolution

Leading the revolution

in Early Cancer Diagnostics

Delivering Early
Cancer Diagnostics

We invest in advanced technologies in blood
drawing and processing methods and
early cancer detection technologies
to compliment our
Group’s primary businesses.

Asia Specific
Footprint

We are focus in delivering
early cancer screening solutions to Asia.
We have our own medical and marketing infrastructure to launch new
innovations successfully into Asia.

About

MiRXES invests in technologies to provide early screening solutions to Asia.

MiRXES Innovation is also an appointed accelerator under Enterprise Singapore’s Sector Specific Accelerator Programme. It has presence in Singapore, Beijing and Hangzhou.

Contact

MiRXES Innovation Logo

SINGAPORE
Corporate Office
2 Tukang Innovation Grove,
#09-02 JTC MedTech Hub, 
Singapore 618305

Email: info@mirxes.com

 

For more information about our technology, click here.

Leading the revolution in Early Cancer Diagnostics